SCHEMBL6968537

SCHEMBL6968537

NC(=O)[C@@H]1CCCCN1S(=O)(=O)CC1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
FKBP1A P62942 4/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHRM5 P08912 1/20 0.32
ADRA2C P18825 1/20 0.32
SPHK1 Q9NYA1 1/20 0.32
MMP1 P03956 1/20 0.32
MMP7 P09237 1/20 0.32
MMP8 P22894 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
EPHX1 P07099 1/20 0.32
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TSHR P16473 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963805 0.85 ALDH1A1 (0.46) FKBP1AALDH1A1MMP8MMP12MMP13
SCHEMBL6959434 0.83 SPHK1 (0.36) FKBP1ACHRM5ADRA2CSPHK1
SCHEMBL6959128 0.83 SPHK1 (0.36) FKBP1ACHRM5ADRA2CSPHK1
SCHEMBL6958233 0.80 JAK2 (0.32) FKBP1AALDH1A1MMP1MMP7MMP13
SCHEMBL6967183 0.80 JAK2 (0.32) FKBP1AALDH1A1MMP1MMP7MMP13
SCHEMBL8132660 0.77 MMP13 (0.35) FKBP1ACHRM5ADRA2CMMP1MMP7
SCHEMBL6969165 0.77 JAK2 (0.30)
SCHEMBL8427907 0.76 SMN1; SMN2 (0.39) FKBP1AALDH1A1SMN1; SMN2MMP1MMP7
SCHEMBL19902090 0.76 SMN1; SMN2 (0.39) FKBP1AALDH1A1SMN1; SMN2MMP1MMP7
SCHEMBL3941213 0.74 LMNA (0.48) ALDH1A1SMN1; SMN2NPSR1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060178-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER (US) 2003-09-03 EP disclosed
US-6610707-B1 Moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases and nerve damage. PFIZER INC. 2003-08-26 US disclosed
EP-1060178-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER INC. (US) 2000-12-20 EP disclosed
WO-1999045006-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER INC. (US) 1999-09-10 WO disclosed